Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C
Clinical trial NCT02817594 · COMPLETED
Trial details
- NCT number
- NCT02817594
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-01-20
- Primary completion
- 2018-03-07
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.